Lucid Diagnostics Inc reports results for the quarter ended September 30 - Earnings Summary
13/11/2024 15:27
* Lucid Diagnostics Inc LUCD.OQ reported a quarterly
adjusted
loss of 25 cents per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -34 cents. The mean expectation of six analysts
for the quarter was for a loss of 22 cents per share. Wall
Street expected results to range from -23 cents to -20 cents per
share.
* Revenue rose 49.7% to $1.17 million from a year ago;
analysts
expected $1.14 million.
* Lucid Diagnostics Inc's reported EPS for the quarter was a
loss
of 25 cents.
* The company reported a quarterly loss of $12.37 million.
* Lucid Diagnostics Inc shares had risen by 22.7% this
quarter and
lost 29.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Lucid Diagnostics
Inc is $3.00
This summary was machine generated from LSEG data November 13 at
03:27 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.22 -0.25 Missed
Jun. 30 2024 -0.22 -0.23 Missed
Mar. 31 2024 -0.27 -0.40 Missed
Dec. 31 2023 -0.26 -0.25 Beat